177 Lu-FAP-2286 Therapy in a Metastatic Bone Malignant Solitary Fibrous Tumor.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38465996.
- Also identified by DOI 10.1097/RLU.0000000000005168.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 57-year-old woman with a metastatic bone malignant solitary fibrous tumor received 177 Lu-FAP-2286 therapy. After 1 treatment cycle, 68 Ga-FAP-2286 PET/CT revealed remission of the lesions. Moreover, the patient did not report any adverse effects.
Medical subject headings
- Positron Emission Tomography Computed Tomography
- Solitary Fibrous Tumors